Hi marzan, I think this time the AF + hedge fund combo won't work simply because nwbo has had so many investors who are really committed because of science for which AF and friends don't understand.
Regardless nwbo will have a cult following by a very large number of retail investors plus perhaps dozens of small long hedge funds.
In my decades of biotech investment, I have never ever come to know so many retain investors who have been unbelievably knowledgeable on how DCVax works, its MOA, and what's the status of GBM clinical trials and treatments, and the current best cares/standard cares, etc.
These investors will not be easily shaken off and let go their collectively huge numbers of shares in case disinformation/fake news/deceptive analysis is released by any of the naked short wolfpack.
In addition, AF's appeal as frontman for short hedges has been severely damaged ever since he left the street due to several high profile bad calls and aftermath consequences. If ever naked short hedges want to conspire with him in the future, the effect will be temporary in my opinion.
We are educated with knowledge of DCVax. Next will be the mainstream media after topline data are released.
Actually the share price movement since around 1 September has been a testament that the wolfpack has been broken, and they will run for the hills. I like to see a stampede aka squeeze, not only for my profit but most importantly for GBM patients!
News 
Market Data 
Discover 
AI
